Skip to main content

Table 3 Sensitivity and specificity of markers in EBNA1 positive NPC samples (n = 36) and non-cancerous controls (n = 18) from Morocco using modified MMSP assay

From: Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay

Marker gene

Sensitivity %(positive cases/total)

Specificity % (total cases − positive cases/total control cases)

U-LMP1

72 (26/36)

94 (17/18)

M-ITGA9

56 (20/36)

100 (18/18)

M-RASSF1A

78 (28/36)

94 (17/18)

M-P16

50 (18/36)

100 (18/18)